Education:
  • MBChB, Bachelor of Medicine, Bachelor of Surgery (University of Birmingham)
  • DIC (Imperial College London)
  • PhD, Doctor of Philosophy (Imperial College London)
  • FRCS (Fellowship of the Royal College of Surgeons of England)
Awards:
  • Over 15 medical awards, including the High Altmetric Score from the British Journal of Surgery
  • Canex 2021 ‘Bringing Treatment to the Masses’ award for the Curaleaf Access Scheme
  • Cannabis Scientist 2022 Power List ‘Inspirational Mentor’
  • Cannavist Most Influential People in CBD & Medical Cannabis 2020
Previous Experience:

Dr. Sodergren’s research focuses on immunomodulatory cancer therapies, medical cannabis, surgical device advancements, and medical eye tracking. He previously held the NIHR TCC Academic Clinical Lectureship in Surgery at Imperial College and pioneered NOTES in the UK.

Doctor Mikael Sodergren

Dr Sodergren is a Senior Clinical Lecturer at Imperial College London and Consultant Hepatobiliary & Pancreatic Surgeon at Imperial College Healthcare NHS Trust. He is also the Chief Medical Officer of Curaleaf International, leading clinical and pre-clinical cannabinoid research, and leads the Imperial College Medical Cannabis Research Group.

Dr Sodergren specialises in complex pancreas, liver, and gallbladder surgeries, including keyhole and robotic techniques. He has published over 150 peer-reviewed articles and holds an internationally patented surgical device.

Doctor Mikael Sodergren has also written in:

Top Articles by Doctor Mikael Sodergren

Real World Data on the Efficacy of Medical Cannabis

24th February 2025

Thank You to our Patient Community: Curaleaf at the 34th Annual International Cannabinoid Research Society Symposium

2nd July 2024

Sapphire’s Access Scheme continues to expand and offer another 2,000 patients access to medical cannabis consultations

4th November 2022

A Review of the Evidence for Medical Cannabis and Multiple Sclerosis 

26th August 2022

Our Other Authors

Dr Erridge specialises in medical cannabis research, with a focus on chronic pain. As Research Director at Curaleaf Clinic, he oversees the UK Medical Cannabis Registry. Dr Erridge has published over 80 peer-reviewed articles and is completing a PhD at Imperial College London. His expertise includes medical technologies and patient-reported outcome measures.
Dr Philipps is a clinical neuroscientist specialising in the endocannabinoid system, medical cannabis, CBD, and integrative medicine. As Clinical Lead at the Medical Cannabis Alliance, she advances cannabinoid medicine research and policy reforms. Dr Philipps empowers health management through lifestyle, diet, and plant-based medicines.
Dr Rucker specialises in mood disorders and novel psychopharmacological treatments for treatment-resistant depression. He leads the Psychoactive Trials Group at the Centre for Affective Disorders and holds a Clinician Scientist Fellowship to investigate psilocybin. Dr Rucker has over 15 years of psychiatric experience and extensive clinical trial expertise.